| 2 CE Credits-Newer Options in the Management of Insomnia JA Dopheide, CA Kushida US Pharmacist 30 (10), 102-113, 2005 | 3 | 2005 |
| A 2015 survey of pharmacy curriculum in psychiatry and neurology in the United States JA Dopheide, JR Bostwick, LW Goldstone, K Gable, KL Thomas, ... | 2 | 2016 |
| A curriculum survey of CPNP members with BCPP credentials and academic affiliations JA Dopheide, LW Goldstone, JR Bostwick, KL Thomas, J Caballero, ... | 1 | 2016 |
| A naturalistic comparison of adverse effects between slow titration and loading of divalproex sodium in psychiatric inpatients WJ Lima, JA Dopheide, BA Kramer, CA Earhart, MZ Wincor Journal of affective disorders 52 (1-3), 261-267, 1999 | 21 | 1999 |
| Acetylcysteine for treatment of autism spectrum disorder symptoms D Stutzman, J Dopheide American Journal of Health-System Pharmacy 72 (22), 1956-1959, 2015 | 16 | 2015 |
| Acknowledgment of reviewers—November 1, 2004, to October 31, 2005 CE Dennehy, K Dennis, PJ Dentinger, AR Desilets, SP Desselle, ... Am J Health-Syst Pharm 62, 2005 | | 2005 |
| Action not reaction J Dopheide Mental Health Clinician 3 (3), 168-168, 2013 | | 2013 |
| An Update on the Pharmacotherapy of Anxiety Disorders J Dopheide, S Park California Journal of Health System Pharmacy 13 (1), 2001 | 1 | 2001 |
| Antipsychotic safety in liver disease: a narrative review and practical guide for the clinician M Gunther, JA Dopheide Journal of the Academy of Consultation-Liaison Psychiatry 64 (1), 73-82, 2023 | 9 | 2023 |
| Antipsychotic selection for acute agitation and time to repeat use in a psychiatric emergency department S Gomez, J Dopheide Journal of Psychiatric Practice® 22 (6), 450-458, 2016 | 12 | 2016 |
| ASHP practitioner recognition program--2015 fellows of the American Society of Health-System Pharmacists VAS Adams, GE Albracht, E Alexander, BD Benson, RJ Bickel, ... American journal of health-system pharmacy 72 (13), 1153-1153, 2015 | | 2015 |
| ASHP therapeutic position statement on the appropriate use of medications in the treatment of attention-deficit/hyperactivity disorder in pediatric patients JA Dopheide American journal of health-system pharmacy 62 (14), 1502-1509, 2005 | 31 | 2005 |
| Attention‐deficit‐hyperactivity disorder: an update JA Dopheide, SR Pliszka Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (6 …, 2009 | 334 | 2009 |
| Best practices for documentation of psychotropic drug-drug interactions in an adult psychiatric clinic K Collins, JA Dopheide, M Wang, T Keshishian Mental Health Clinician 13 (1), 11-17, 2023 | 1 | 2023 |
| Changing manufacturer to address neutropenia induced by non-clozapine second-generation antipsychotics: Changing antipsychotic manufacturer to address neutropenia HI Kim, JA Dopheide Journal of the American Pharmacists Association 62 (4), 1441-1445, 2022 | | 2022 |
| Childhood disorders JA Dopheide, JT Tesoro, M Malkin Pharmacotherapy: A pathophysiologic approach 2008, 1029-1040, 2008 | 23 | 2008 |
| Collaboration between child and adolescent psychiatrists and mental health pharmacists to improve treatment outcomes DH Lu, JA Dopheide, D Wang, JK Jeffrey, S Chen Child and Adolescent Psychiatric Clinics 30 (4), 797-808, 2021 | 11 | 2021 |
| Community Wellness through Depression Recovery JA Dopheide Keck School of Medicine, 0 | | |
| CPNP 2019 Annual Meeting Poster Abstracts MBA Leshcorn, A Hebbard | | |
| CPNP 2020 Annual Meeting Poster Abstracts C Dorflinger, H Carey, J Roche, C Burant, C LeHew, H Stewart, B Mitchell, ... The Mental Health Clinician 10 (3), 104-206, 2020 | | 2020 |
